Skip to main content
SpringerLink
Log in

90y-dotatate/octreotate-lu-177-dota-tyr-3

Myelodysplastic syndrome and nephrotoxicity: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kunikowska J, et al. Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study. Annals of Nuclear Medicine 31: 347-356, No. 5, Jun 2017. Available from: URL: http://doi.org/10.1007/s12149-017-1163-6 - Poland

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

90y-dotatate/octreotate-lu-177-dota-tyr-3. Reactions Weekly 1661, 13 (2017). https://doi.org/10.1007/s40278-017-33301-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-33301-x

Search

Navigation